These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Glycosylation in cellular mechanisms of health and disease. Ohtsubo K; Marth JD Cell; 2006 Sep; 126(5):855-67. PubMed ID: 16959566 [TBL] [Abstract][Full Text] [Related]
45. Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Devadas S; Das J; Liu C; Zhang L; Roberts AI; Pan Z; Moore PA; Das G; Shi Y Immunity; 2006 Aug; 25(2):237-47. PubMed ID: 16901729 [TBL] [Abstract][Full Text] [Related]
46. Inflaming the CD8+ T cell response. Haring JS; Badovinac VP; Harty JT Immunity; 2006 Jul; 25(1):19-29. PubMed ID: 16860754 [TBL] [Abstract][Full Text] [Related]
47. The sialyltransferase ST3Gal-I is not required for regulation of CD8-class I MHC binding during T cell development. Kao C; Sandau MM; Daniels MA; Jameson SC J Immunol; 2006 Jun; 176(12):7421-30. PubMed ID: 16751387 [TBL] [Abstract][Full Text] [Related]
48. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules. Zhang M; Park SM; Wang Y; Shah R; Liu N; Murmann AE; Wang CR; Peter ME; Ashton-Rickardt PG Immunity; 2006 Apr; 24(4):451-61. PubMed ID: 16618603 [TBL] [Abstract][Full Text] [Related]
49. Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. Han S; Collins BE; Bengtson P; Paulson JC Nat Chem Biol; 2005 Jul; 1(2):93-7. PubMed ID: 16408005 [TBL] [Abstract][Full Text] [Related]
50. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Ohtsubo K; Takamatsu S; Minowa MT; Yoshida A; Takeuchi M; Marth JD Cell; 2005 Dec; 123(7):1307-21. PubMed ID: 16377570 [TBL] [Abstract][Full Text] [Related]
51. Granzyme B, a new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in Th2 but not Th1 effectors. Sharma V; Delgado M; Ganea D J Immunol; 2006 Jan; 176(1):97-110. PubMed ID: 16365400 [TBL] [Abstract][Full Text] [Related]
52. Apoptotic pathways: ten minutes to dead. Green DR Cell; 2005 Jun; 121(5):671-4. PubMed ID: 15935754 [TBL] [Abstract][Full Text] [Related]
53. The role of BH3-only proteins in the immune system. Strasser A Nat Rev Immunol; 2005 Mar; 5(3):189-200. PubMed ID: 15719025 [TBL] [Abstract][Full Text] [Related]
55. CD8+ T cell contraction is controlled by early inflammation. Badovinac VP; Porter BB; Harty JT Nat Immunol; 2004 Aug; 5(8):809-17. PubMed ID: 15247915 [TBL] [Abstract][Full Text] [Related]
56. Ligation of CD8 leads to apoptosis of thymocytes that have not undergone positive selection. Grebe KM; Clarke RL; Potter TA Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10410-5. PubMed ID: 15232005 [TBL] [Abstract][Full Text] [Related]
57. Peanut agglutinin high phenotype of activated CD8+ T cells results from de novo synthesis of CD45 glycans. Amado M; Yan Q; Comelli EM; Collins BE; Paulson JC J Biol Chem; 2004 Aug; 279(35):36689-97. PubMed ID: 15210702 [TBL] [Abstract][Full Text] [Related]
58. Control of T cell viability. Marrack P; Kappler J Annu Rev Immunol; 2004; 22():765-87. PubMed ID: 15032596 [TBL] [Abstract][Full Text] [Related]
59. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Fukumori T; Takenaka Y; Yoshii T; Kim HR; Hogan V; Inohara H; Kagawa S; Raz A Cancer Res; 2003 Dec; 63(23):8302-11. PubMed ID: 14678989 [TBL] [Abstract][Full Text] [Related]